Hi Gun -- like everyone else, my guess depends on

Hi Gun --
like everyone else, my guess depends on what indications Leron will be used for in a year's time. I do think it will be approved for Covid, and for HIV (cocktail) ; but both of those are either crowded fields (HIV) or gradually narrowing fields (severe Covid). Can accept $20 SP based on Covid, and another $15 for HIV -- don't think the monotherapy will be approved in one year's time. But I ALSO think the Long Hauler Covid indication will come into play a lot sooner. Right now the world has 21 million active cases, and the US almost 7 million (a shocking ratio). The US alone has 29000 serious/critical cases, the world over 110K. And that's just people who have serious cases right now. So I see millions of courses being sold in a year's time for Long Hauler Covid. And a share price of, let me see, what does it say here: okay, I see, we will have a $62.12 closing share price Dec. 17th, 2021. Give or take a few cents.